Better, faster and more accessible healthcare, enabling world-class leadership teams to succeed on the global stage.
Since October 2015 we have invested €4bn in 24 platform companies across three flagship funds. We have added 60+ companies to our platform, realising transatlantic growth and accessing Asian markets - we put our teams and their companies on the global stage in specialist healthcare markets.
Biocare Medical is a leading developer of oncology focused immunohistochemistry (IHC) and in situ hybridisation (ISH) reagents for diagnosis and chromosomal profiling alongside an array of diagnostics instruments.
Velocity Clinical Research is a Site Management Organisation (‘SMO’) managing clinical trial sites across North America with a focus across infectious diseases, vaccine trials and general medicine therapeutic areas.